CDDO-Me, Sulforaphane and tBHQ attenuate the RANKL-induced osteoclast differentiation via activating the NRF2-mediated antioxidant response
- 1 April 2019
- journal article
- research article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 511 (3) , 637-643
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health (NIH NIDCR R01DE022816)
This publication has 29 references indexed in Scilit:
- OsteoporosisThe Lancet, 2019
- Effect of genetic variants of OPTN in the pathophysiology of Paget's disease of boneBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2018
- Sulforaphane inhibits osteoclast differentiation by suppressing the cell-cell fusion molecules DC-STAMP and OC-STAMPBiochemical and Biophysical Research Communications, 2017
- RANKL induces Bach1 nuclear import and attenuates Nrf2‐mediated antioxidant enzymes, thereby augmenting intracellular reactive oxygen species signaling and osteoclastogenesis in miceThe FASEB Journal, 2016
- Dimethyl fumarate and the oleanane triterpenoids, CDDO-imidazolide and CDDO-methyl ester, both activate the Nrf2 pathway but have opposite effects in the A/J model of lung carcinogenesisCarcinogenesis, 2015
- The Effect of Ex Vivo CDDO-Me Activation on Nuclear Factor Erythroid 2–Related Factor 2 Pathway in White Blood Cells From Patients With Septic ShockShock, 2014
- Nrf2 deficiency induces oxidative stress and promotes RANKL-induced osteoclast differentiationFree Radical Biology and Medicine, 2013
- Prolonged inorganic arsenite exposure suppresses insulin-stimulated AKT S473 phosphorylation and glucose uptake in 3T3-L1 adipocytes: Involvement of the adaptive antioxidant responseBiochemical and Biophysical Research Communications, 2011
- The synthetic triterpenoid CDDO-methyl ester modulates microglial activities, inhibits TNF production, and provides dopaminergic neuroprotectionJournal of Neuroinflammation, 2008
- Preclinical Evaluation of Targeting the Nrf2 Pathway by Triterpenoids (CDDO-Im and CDDO-Me) for Protection from LPS-Induced Inflammatory Response and Reactive Oxygen Species in Human Peripheral Blood Mononuclear Cells and NeutrophilsAntioxidants & Redox Signaling, 2007